19080sek
1,7 %
Date:2024-07-24Time:17:29:56Latest report:Q2-2024List:Large CapTicker:BIOT
Market Cap:15 391 msekEnterprise Value:15 327 msekNet Sales:2 077 msekEarnings:250,0 msekEmployees:0ISIN:SE0000454746

Ratios

10-year key figure history for Biotage turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Biotage with index and moving average MA50 and MA200.

Stockprice:190,80
MA50:173,50
MA200:151,47
Price/MA200:26,0 %
RSI (14):66,6
Price/MA50:10,0 %

Description

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Medical Equipment